Alphabet spinoff SandboxAQ is teaming up with iOncologi to build a new mRNA vaccine for a common and aggressive brain tumor ...

Days after JCR Pharmaceuticals signed a deal with AstraZeneca’s rare disease unit, the Japanese biopharma has secured a ...

New University of Virginia School of Medicine research suggests an unexpected way doctors may be able to improve blood flow to the brain to battle Alzheimer's and other neurodegenerative diseases.

EQS-News: BRAIN Biotech AG / Key word (s): InvestmentBRAIN Biotech announces buy-out of minorities, new continental European production site, and expansion of its Baking Application Center 20.05.2025 ...

So spare a thought for the long term shareholders of BRAIN Biotech AG (ETR:BNN); the share price is down a whopping 72% in the last three years. That would be a disturbing experience.

BRAIN Biotech Group generated €25.2 million in revenue during the first half of the fiscal year, which is a 7.2 % decrease from the previous year (€27.2 million).

The risk of pharma bribery, the risk of brain drain, and other risks (and rewards) in the biotech landscape this week.

With the business potentially at an important milestone, we thought we'd take a closer look at BRAIN Biotech AG's (ETR:BNN) future prospects. BRAIN Biotech AG provides bio-based products and solutions ...

NeOnc, Inc — a biotech company headed by neurosurgeon Dr. Thomas Chen — has developed a nasal brain delivery system that transports medications via a cranial-to-brain delivery, bypassing the ...

An Australian biotech company developing next-gen anti-inflammatory drugs has announced its breakthrough dementia treatment, designed to preserve the integrity of vital brain cell structures and ...

Now, biotech company NeOnc has developed a new drug delivery system that just might revolutionize the lives of brain cancer patients.